Assessing India's Uniform Code of Pharmaceutical Marketing Practices 2024

A Skeptical Perspective

Authors

  • Editorial Team IndraStra Global IndraStra Global Publishing Solutions Inc.

DOI:

https://doi.org/10.5281/

Keywords:

Uniform Code of Pharmaceutical Marketing Practices, India, Pharmaceutical Marketing

Abstract

The recent Indian government directive aims to curb pharmaceutical companies' practice of enticing doctors to prescribe their medications through various inducements such as gifts, vacations, and educational materials. The 10-page document, titled the Uniform Code of Pharmaceutical Marketing Practices (UCPMP) 2024, delineates a set of regulations for the industry to adhere to in the marketing and promotion of pharmaceutical products. However, despite the government's efforts, there are doubts about the effectiveness of the UCPMP in achieving its intended goals.

Downloads

Published

2024-03-20

Issue

Vol. 10 No. 3 (2024): March

Section

Opinions

License

Copyright (c) 2024 IndraStra Global Publishing Solutions Inc.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

Assessing India’s Uniform Code of Pharmaceutical Marketing Practices 2024: A Skeptical Perspective. (2024). IndraStra Global, 10(3). https://doi.org/10.5281/